Gregory Piazza
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma (NCT02958969) | Gregory Piazza | 2018-02-28 |
Track Gregory Piazza automatically
Every clearance here is in the API, with alerts when new ones post.